Long-Read Sequencing Services Market Report 2026

The long‑read sequencing services market size has grown rapidly in recent years. It will grow from $1.18 billion in 2025 to $1.41 billion in 2026 at a compound annual growth rate (CAGR) of 18.9%. The growth in the historic period can be attributed to advancements in sequencing chemistry and instruments, increased funding for genomics research, rising demand for high-resolution genome analysis, expansion of academic genomics projects, availability of specialized sequencing service providers.

The long‑read sequencing services market size is expected to see rapid growth in the next few years. It will grow to $2.79 billion in 2030 at a compound annual growth rate (CAGR) of 18.6%. The growth in the forecast period can be attributed to increasing clinical adoption of long-read sequencing, rising investments in population genomics, expansion of precision oncology research, growing demand for de novo genome assembly, integration of ai-based genomic interpretation. Major trends in the forecast period include increasing demand for structural variant analysis services, rising adoption of nanopore sequencing platforms, growing use of long-read sequencing in rare disease research, expansion of clinical-grade long-read sequencing services, enhanced focus on comprehensive genome assembly.

The rising prevalence of genetic disorders is expected to drive the growth of the long-read sequencing services market going forward. Genetic disorders arise from DNA mutations that affect health and development. Their increasing prevalence is linked to improved awareness and advanced diagnostic technologies. Long-read sequencing services enable accurate detection of complex genetic variations, supporting improved diagnosis and management. For instance, in April 2024, the National Institutes of Health reported that Alzheimer’s cases among Americans aged 65 and older are projected to nearly double by 2060. Therefore, the rising prevalence of genetic disorders is driving the growth of long-read sequencing services.

Leading companies operating in the long-read sequencing services market are focusing on developing innovative solutions, such as primary template-directed amplification (PTA), which enables high-fidelity, uniform whole-genome amplification from single cells by supporting sensitive detection of single-nucleotide variants (SNVs). Primary template-directed amplification is a proprietary whole-genome amplification technique designed to accurately and uniformly amplify deoxyribonucleic acid (DNA) from ultra-low input samples by reducing errors and preserving the original DNA sequence. For instance, in October 2025, BioSkryb Genomics, Inc., a US-based genomics company specializing in long-read sequencing technologies, launched the ResolveSEQ LongRead Early Access Program, an advanced single-cell whole-genome long-read sequencing platform that integrates primary template-directed amplification (PTA) with long-read library preparation to deliver high-coverage, uniform amplification from individual cells. Additionally, the platform supports sensitive detection of single-nucleotide variants (SNVs) and repeat expansions while enabling haplotype phasing at single-cell resolution.

In March 2024, Clinical Microbiomics, a Denmark-based microbiome science company specializing in multi-omics and microbiome research services, acquired DNASense Anpartsselskab for an undisclosed amount. Through this acquisition, Clinical Microbiomics intends to expand its long-read DNA and RNA sequencing capabilities, particularly for advanced microbial community analysis, by integrating DNASense’s long-read sequencing technologies and bioinformatics expertise. DNASense Anpartsselskab is a Denmark-based biotechnology company specializing in long-read DNA and RNA sequencing technologies and associated bioinformatics.

Major companies operating in the long‑read sequencing services market are Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies Inc., Illumina Inc., Revvity Inc., QIAGEN N.V., BGI Genomics Co. Ltd., Takara Bio Inc., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., GENEWIZ Inc., Macrogen Inc., Novogene Co. Ltd., DNAnexus Inc., Zymo Research Corp., CD Genomics Inc., Genotypic Technology Pvt. Ltd., Plasmidsaurus Inc., BaseClear B.V., GrandOmics Biosciences Co. Ltd., Arima Genomics Inc., Wuhan Benagen Technology Co. Ltd.

North America was the largest region in the long‑read sequencing services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the long‑read sequencing services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the long‑read sequencing services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the long-read sequencing services market by increasing costs of imported sequencing instruments, flow cells, reagents, and high-throughput data processing hardware. Academic institutes, hospitals, and biopharmaceutical companies in North America and Europe are most affected due to reliance on specialized imported platforms, while Asia-Pacific faces higher costs for sequencing consumables. These tariffs are raising service pricing and extending project timelines. However, they are also encouraging regional sequencing infrastructure development, localized reagent production, and strategic partnerships to stabilize long-term service delivery.

The long‑read sequencing services market research report is one of a series of new reports that provides long‑read sequencing services market statistics, including long‑read sequencing services industry global market size, regional shares, competitors with a long‑read sequencing services market share, detailed long‑read sequencing services market segments, market trends and opportunities, and any further data you may need to thrive in the long‑read sequencing services industry. This long‑read sequencing services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Long-read sequencing services are specialized genomics services that generate high-resolution DNA or RNA sequence data by analyzing long, continuous nucleotide sequences. These services support more precise genome assembly, identification of structural variations, and examination of complex genomic regions. They are used to deliver deeper insights into genetic composition, disease processes, and microbial diversity, aiding research, clinical diagnostics, and biopharmaceutical development.

The primary service types of long-read sequencing services are whole genome sequencing, targeted sequencing, de novo sequencing, and others. Whole genome sequencing within long-read sequencing services involves determining the complete DNA sequence of an organism’s genome in a single continuous read format, enabling detailed analysis of structural variants and complex genomic regions. Technologies used include single-molecule real-time sequencing, nanopore sequencing, and others and are applied in clinical diagnostics, genomic research, oncology, rare disease identification, and other areas, serving end-users such as academic and research institutes, hospitals and clinics, pharmaceutical and biotechnology companies, and others.

The long-read sequencing services market includes revenues earned by entities through target enrichment, metagenomic sequencing, epigenetic modification analysis, microbial genome sequencing, and human leukocyte antigen (HLA) typing services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.